Qiagen N.V. (ETR:QIA)

Market Cap	7.94B
Revenue (ttm)	1.91B
Net Income (ttm)	80.74M
Shares Out	n/a
EPS (ttm)	0.36
PE Ratio	98.30
Forward PE	n/a
Dividend	1.21 (3.27%)
Ex-Dividend Date	Jan 29, 2025

Volume	60,839
Average Volume	594,018
Open	36.85
Previous Close	36.84
Day's Range	36.77 - 37.13
52-Week Range	35.25 - 47.36
Beta	0.44
RSI	44.15
Earnings Date	Apr 28, 2025

About Qiagen

Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for n...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 5,700
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: QIA

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD